Chugai Pharmaceutical Co., Ltd. (CHGCY)

Chugai Pharmaceutical Co. Revenue

Chugai Pharmaceutical Co. had revenue of 1.04T JPY in the twelve months ending March 31, 2024, down -14.49% year-over-year. Revenue in the quarter ending March 31, 2024 was 236.95B JPY, a -24.11% decrease year-over-year. In the year 2023, Chugai Pharmaceutical Co. had annual revenue of 1.11T JPY, a decrease of -11.79%.

• Revenue (ttm): 1,036.08B JPY
• Revenue Growth: -14.49%
• P/S Ratio: 9.53
• Revenue / Employee: 136,253,945 JPY
• Employees: 7,604
• Market Cap: 61.08B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1,111.37B	-148.58B	-11.79%
Dec 31, 2022	1,259.95B	260.19B	26.02%
Dec 31, 2021	999.76B	212.81B	27.04%
Dec 31, 2020	786.95B	100.76B	14.68%
Dec 31, 2019	686.18B	106.40B	18.35%
Dec 31, 2018	579.79B	45.59B	8.53%
Dec 31, 2017	534.20B	42.42B	8.63%
Dec 31, 2016	491.78B	-7.06B	-1.42%
Dec 31, 2015	498.84B	37.73B	8.18%
Dec 31, 2014	461.11B	37.46B	8.84%
Dec 31, 2013	423.65B	32.43B	8.29%
Dec 31, 2012	391.22B	17.70B	4.74%
Dec 31, 2011	373.52B	-5.99B	-1.58%
Dec 31, 2010	379.51B	-49.44B	-11.53%
Dec 31, 2009	428.95B	102.01B	31.20%
Dec 31, 2008	326.94B	-17.87B	-5.18%
Dec 31, 2007	344.81B	18.71B	5.74%
Dec 31, 2006	326.10B	-1.06B	-0.32%
Dec 31, 2005	327.16B	32.49B	11.02%
Dec 31, 2004	294.67B	61.92B	26.60%
Dec 31, 2003	232.75B	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.